Skip to content

Effect of supplement foods on accommodation of eye

Effect of supplement foods on accommodation of eye - Effect of supplement foods on accommodation of eye

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044905
Enrollment
60
Registered
2021-07-20
Start date
2021-06-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (Healthy adults)

Interventions

Take supplement food once daily for 12 weeks Take placebo once daily for 12 weeks

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Both eyes with visual acuity of 0.7 or more (uncorrected or corrected) Those who are aware of continuous eye fatigue after more than 4 hours VDT operation per day. Those who are can visited clinic on schedule and can be performed planned examinations and observations.

Exclusion criteria

Exclusion criteria: Those who have any complication other than refractive error (eyes or whole body). Those who have a history of ocular surgery or are scheduled during the study period (including refractive corneal surgery and laser therapy). Those who cannot discontinued drugs for the eye or eyelid during the study period (including OTC drugs). Those who have changed lens powers of contact lenses or glasses within the past month or are scheduled to be changed during the study period. Those who have continuous consumption of health foods (including supplements) within the past 3 months or will be consumed during the study period. Those who plan to smoke during the study period. Those who have hypersensitivity to test food. Those who have a history of drug allergy or food allergy.

Design outcomes

Primary

MeasureTime frame
Changes in accommodation of eye

Countries

Japan

Contacts

Public ContactYasutaka Takagi

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs

clinical@santen.co.jp06-4802-9337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026